COST-EFFECTIVENESS ANALYSIS OF LIRAGLUTIDE VERSUS SITAGLIPTIN OR
EXENATIDE IN PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES ON
ORAL ANTIDIABETIC DRUGS IN GREECE
COST-EFFECTIVENESS ANALYSIS OF LIRAGLUTIDE VERSUS SITAGLIPTIN OR EXENATIDE IN PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES ON ORAL ANTIDIABETIC DRUGS IN GREECE
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2014
Συγγραφείς:
Tzanetakos, C. Melidonis, A. Verras, C. Kourlaba, G. and Maniadakis, N.
